Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,520 | -2,410 | -930 | -5,990 | -4,930 |
| Depreciation Amortization | 160 | 80 | 40 | 160 | 120 |
| Other Working Capital | 750 | -1,060 | -1,570 | -130 | -940 |
| Other Operating Activity | 10 | 0 | 0 | 240 | 250 |
| Operating Cash Flow | $-5,600 | $-3,390 | $-2,460 | $-5,720 | $-5,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -660 | -160 | -50 | -80 | -70 |
| Other Investing Activity | 0 | 0 | 0 | 10,300 | 10,310 |
| Investing Cash Flow | $-660 | $-160 | $-50 | $10,220 | $10,240 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1 | 0 | 0 | 0 | 0 |
| Other Financing Activity | 351 | 330 | 20 | 13,390 | 200 |
| Financing Cash Flow | $350 | $330 | $20 | $13,390 | $200 |
| Beginning Cash Position | 19,010 | 19,010 | 19,010 | 1,110 | 1,110 |
| End Cash Position | 13,100 | 15,780 | 16,520 | 19,010 | 6,050 |
| Net Cash Flow | $-5,910 | $-3,220 | $-2,490 | $17,890 | $4,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,600 | -3,390 | -2,460 | -5,720 | -5,500 |
| Free Cash Flow | -5,600 | -3,390 | -2,460 | -5,720 | -5,500 |